Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67

1.

Novel in vitro model for studying hepatic ischemia-reperfusion injury using liver cubes.

DuBray BJ Jr, Conzen KD, Upadhya GA, Balachandran P, Jia J, Knolhoff BL, Alpers DH, Mohanakumar T, Chapman WC, Anderson CD.

Surgery. 2012 Aug;152(2):247-53. doi: 10.1016/j.surg.2012.02.012. Epub 2012 Jun 13.

2.

Ischemic preconditioning improves liver tolerance to congestion-reperfusion injury in mice.

Zhang Q, Yan S, Tian Y, Ding Y, Yao J, Chen H, Feng Z, Owusu-Ansah K, Zheng S.

J Surg Res. 2014 Jun 1;189(1):152-8. doi: 10.1016/j.jss.2014.01.061. Epub 2014 Feb 5.

PMID:
24589179
3.

Reduction of hepatic ischemia/reperfusion injury by a soluble P-selectin glycoprotein ligand-1.

Dulkanchainun TS, Goss JA, Imagawa DK, Shaw GD, Anselmo DM, Kaldas F, Wang T, Zhao D, Busuttil AA, Kato H, Murray NG, Kupiec-Weglinski JW, Busuttil RW.

Ann Surg. 1998 Jun;227(6):832-40.

4.

Cathepsin B inactivation attenuates the apoptotic injury induced by ischemia/reperfusion of mouse liver.

Ben-Ari Z, Mor E, Azarov D, Sulkes J, Tor R, Cheporko Y, Hochhauser E, Pappo O.

Apoptosis. 2005 Dec;10(6):1261-9.

PMID:
16215674
5.

Proliferative activity in ischemia/reperfusion injury in hepatectomized mice: effect of N-acetylcysteine.

Silva SM, Carbonel AA, Taha MO, Simões MJ, Montero EF.

Transplant Proc. 2012 Oct;44(8):2321-5. doi: 10.1016/j.transproceed.2012.07.009.

6.
7.

Systemic administration of autologous adipose-derived mesenchymal stem cells alleviates hepatic ischemia-reperfusion injury in rats.

Sun CK, Chang CL, Lin YC, Kao YH, Chang LT, Yen CH, Shao PL, Chen CH, Leu S, Yip HK.

Crit Care Med. 2012 Apr;40(4):1279-90. doi: 10.1097/CCM.0b013e31823dae23.

PMID:
22336724
8.

Hepatic energy metabolism and the differential protective effects of sevoflurane and isoflurane anesthesia in a rat hepatic ischemia-reperfusion injury model.

Bedirli N, Ofluoglu E, Kerem M, Utebey G, Alper M, Yilmazer D, Bedirli A, Ozlu O, Pasaoglu H.

Anesth Analg. 2008 Mar;106(3):830-7, table of contents. doi: 10.1213/ane.0b013e3181616fc9.

PMID:
18292427
9.

Exaggerated up-regulation of tumor necrosis factor alpha-dependent apoptosis in the older mouse liver following reperfusion injury: targeting liver protective strategies to patient age.

Selzner M, Selzner N, Chen L, Borozan I, Sun J, Xue-Zhong M, Zhang J, McGilvray ID.

Liver Transpl. 2009 Nov;15(11):1594-604. doi: 10.1002/lt.21864.

10.

Effect of selective versus non-selective cyclooxygenase inhibitors on ischemia-reperfusion-induced hepatic injury in rats.

Abdel-Gaber SA, Ibrahim MA, Amin EF, Ibrahim SA, Mohammed RK, Abdelrahman AM.

Life Sci. 2015 Aug 1;134:42-8. doi: 10.1016/j.lfs.2015.04.025. Epub 2015 May 23.

PMID:
26006041
11.

Interleukin 18 causes hepatic ischemia/reperfusion injury by suppressing anti-inflammatory cytokine expression in mice.

Takeuchi D, Yoshidome H, Kato A, Ito H, Kimura F, Shimizu H, Ohtsuka M, Morita Y, Miyazaki M.

Hepatology. 2004 Mar;39(3):699-710.

PMID:
14999688
12.

Modulation of mitochondrial calcium management attenuates hepatic warm ischemia-reperfusion injury.

Anderson CD, Pierce J, Nicoud I, Belous A, Knox CD, Chari RS.

Liver Transpl. 2005 Jun;11(6):663-8.

13.

Hydrodynamics-based transfection of plasmid encoding receptor activator for nuclear factor kappa B-Fc protects against hepatic ischemia/reperfusion injury in mice.

Shi J, Shao W, Yang D, Zhao L, Deng L, Wang X, Sun B.

Liver Transpl. 2010 May;16(5):611-20. doi: 10.1002/lt.22030.

14.

Inhibiting the toll-like receptor 4 Toll/interleukin-1 receptor domain protects against hepatic warm ischemia and reperfusion injury in mice.

Meimei H, Dejin M, Erzhen C, Minmin S, Songyao J, Jianfang L, Hao C.

Crit Care Med. 2014 Feb;42(2):e123-31. doi: 10.1097/CCM.0b013e3182a647c1.

PMID:
24231763
15.

Effect of remote ischemic preconditioning on liver ischemia/reperfusion injury using a new mouse model.

Abu-Amara M, Yang SY, Quaglia A, Rowley P, Tapuria N, Seifalian AM, Fuller BJ, Davidson BR.

Liver Transpl. 2011 Jan;17(1):70-82. doi: 10.1002/lt.22204.

16.

Ischemia and reperfusion liver injury is reduced in the absence of Toll-like receptor 4.

Ben-Ari Z, Avlas O, Fallach R, Schmilovitz-Weiss H, Chepurko Y, Pappo O, Hochhauser E.

Cell Physiol Biochem. 2012;30(2):489-98. doi: 10.1159/000341432. Epub 2012 Jul 13.

17.

Low-dose TNF-alpha protects against hepatic ischemia-reperfusion injury in mice: implications for preconditioning.

Teoh N, Leclercq I, Pena AD, Farrell G.

Hepatology. 2003 Jan;37(1):118-28.

PMID:
12500196
18.

Requirement for interleukin-12 in the pathogenesis of warm hepatic ischemia/reperfusion injury in mice.

Lentsch AB, Yoshidome H, Kato A, Warner RL, Cheadle WG, Ward PA, Edwards MJ.

Hepatology. 1999 Dec;30(6):1448-53.

PMID:
10573524
19.

Vasoactive intestinal peptide attenuates liver ischemia/reperfusion injury in mice via the cyclic adenosine monophosphate-protein kinase a pathway.

Ji H, Zhang Y, Liu Y, Shen XD, Gao F, Nguyen TT, Busuttil RW, Waschek JA, Kupiec-Weglinski JW.

Liver Transpl. 2013 Sep;19(9):945-56. doi: 10.1002/lt.23681. Epub 2013 Jul 26.

20.

PTPRO plays a dual role in hepatic ischemia reperfusion injury through feedback activation of NF-κB.

Hou J, Xia Y, Jiang R, Chen D, Xu J, Deng L, Huang X, Wang X, Sun B.

J Hepatol. 2014 Feb;60(2):306-12. doi: 10.1016/j.jhep.2013.09.028. Epub 2013 Oct 12.

PMID:
24128416

Supplemental Content

Support Center